CVCT Forum
@cvctforum.bsky.social
A Forum for #CardioVascular Clinical Trialists. Best update on the latest clinical trials of the year!
https://www.globalcvctforum.com/
22nd CVCT Forum |
December 8-10, 2025
https://www.globalcvctforum.com/
22nd CVCT Forum |
December 8-10, 2025
Discussions on the utility of beta-blockers in post-MI patients 'been ongoing for the last 50 years. Early trials documented survival benefits for MI patients, but the entire therapeutic landscape has undergone fundamental changes based on revascularization strategies and post-infarction prevention.
November 21, 2025 at 6:18 PM
Discussions on the utility of beta-blockers in post-MI patients 'been ongoing for the last 50 years. Early trials documented survival benefits for MI patients, but the entire therapeutic landscape has undergone fundamental changes based on revascularization strategies and post-infarction prevention.
#CVCT2025: “CKLM BIOLOGICS: From Concept to Clinic” — a deep dive into overcoming translational & regulatory barriers for next-gen cardiovascular therapies.
Global leaders will discuss cardiogenic shock, RNA & antibody platforms, AI, biomarkers, bench to bedside success stories and trial innovation.
Global leaders will discuss cardiogenic shock, RNA & antibody platforms, AI, biomarkers, bench to bedside success stories and trial innovation.
November 5, 2025 at 4:51 PM
#CVCT2025: “CKLM BIOLOGICS: From Concept to Clinic” — a deep dive into overcoming translational & regulatory barriers for next-gen cardiovascular therapies.
Global leaders will discuss cardiogenic shock, RNA & antibody platforms, AI, biomarkers, bench to bedside success stories and trial innovation.
Global leaders will discuss cardiogenic shock, RNA & antibody platforms, AI, biomarkers, bench to bedside success stories and trial innovation.
NEW at #CVCT2025: The Cynthia Chauhan Trailblazer Award, named for CVCT’s founding Patient Trialist, is presented to a researcher who has demonstrated exemplary commitment to patient engagement in clinical research.
October 30, 2025 at 7:28 PM
NEW at #CVCT2025: The Cynthia Chauhan Trailblazer Award, named for CVCT’s founding Patient Trialist, is presented to a researcher who has demonstrated exemplary commitment to patient engagement in clinical research.
#CVCT2025: The Think Tank we have assembled around EVOLUTION OF NEW THERAPIES FOR HYPERTENSION - WHAT IS THEIR PLACE IN MODERN TREATMENT STRATEGIES? will discuss the extraordinary renaissance of new therapies for the treatment of hypertension at various stages in drug development.
October 24, 2025 at 3:14 PM
#CVCT2025: The Think Tank we have assembled around EVOLUTION OF NEW THERAPIES FOR HYPERTENSION - WHAT IS THEIR PLACE IN MODERN TREATMENT STRATEGIES? will discuss the extraordinary renaissance of new therapies for the treatment of hypertension at various stages in drug development.
#CVCT2025: Browse our scientific program and join us, December 8-10, Washington DC!
www.globalcvctforum.com/scientific-p...
#CVCT #clinicaltrials #clinicalresearch
www.globalcvctforum.com/scientific-p...
#CVCT #clinicaltrials #clinicalresearch
October 21, 2025 at 12:43 PM
#CVCT2025: Browse our scientific program and join us, December 8-10, Washington DC!
www.globalcvctforum.com/scientific-p...
#CVCT #clinicaltrials #clinicalresearch
www.globalcvctforum.com/scientific-p...
#CVCT #clinicaltrials #clinicalresearch
#CVCT2025: How can gene therapy be effectively implemented in rare and complex cardiovascular conditions? This section addresses patient selection, the design of adaptive clinical trials, and regulatory pathways tailored for orphan populations.
October 14, 2025 at 4:49 PM
#CVCT2025: How can gene therapy be effectively implemented in rare and complex cardiovascular conditions? This section addresses patient selection, the design of adaptive clinical trials, and regulatory pathways tailored for orphan populations.
We’re excited to share an important update:
1. Abstract Submissions – New Deadline: October 20, 2025
We are now accepting abstracts from both industry and academic contributors.
👉Find the guidelines and the submission link here: : www.globalcvctforum.com/poster-prese...
1. Abstract Submissions – New Deadline: October 20, 2025
We are now accepting abstracts from both industry and academic contributors.
👉Find the guidelines and the submission link here: : www.globalcvctforum.com/poster-prese...
October 10, 2025 at 1:18 PM
We’re excited to share an important update:
1. Abstract Submissions – New Deadline: October 20, 2025
We are now accepting abstracts from both industry and academic contributors.
👉Find the guidelines and the submission link here: : www.globalcvctforum.com/poster-prese...
1. Abstract Submissions – New Deadline: October 20, 2025
We are now accepting abstracts from both industry and academic contributors.
👉Find the guidelines and the submission link here: : www.globalcvctforum.com/poster-prese...
#iCVCT2025: At iCVCT, there will be a unique menu of sessions covering clinical trial design and regulatory considerations for cardiovascular devices. I am particularly excited about the session on Controversies in Clinical Trial Design for Structural Heart Interventions.
October 3, 2025 at 5:06 PM
#iCVCT2025: At iCVCT, there will be a unique menu of sessions covering clinical trial design and regulatory considerations for cardiovascular devices. I am particularly excited about the session on Controversies in Clinical Trial Design for Structural Heart Interventions.
#CVCT2025: This year, you have the opportunity to share impactful, cutting-edge results on a global stage and to contribute to shaping the future of innovative therapies and clinical trial science.
October 1, 2025 at 7:22 AM
#CVCT2025: This year, you have the opportunity to share impactful, cutting-edge results on a global stage and to contribute to shaping the future of innovative therapies and clinical trial science.
#CVCT2025: Even though outcomes of the early cell therapy trials have not matched the expectations, the concept of leveraging the bioactivity of cells for improving cardiac function in heart failure is still under active development and research now spans the main following areas:
September 25, 2025 at 9:17 PM
#CVCT2025: Even though outcomes of the early cell therapy trials have not matched the expectations, the concept of leveraging the bioactivity of cells for improving cardiac function in heart failure is still under active development and research now spans the main following areas:
#CVCT2025: The Think Tank we have assembled around Clinical Trial on Breakthrough devices in the US and the EU will discuss the undergoing changes in the EU and the US and their impact on the holistic regulatory and clinical strategies and timelines.
September 19, 2025 at 4:45 PM
#CVCT2025: The Think Tank we have assembled around Clinical Trial on Breakthrough devices in the US and the EU will discuss the undergoing changes in the EU and the US and their impact on the holistic regulatory and clinical strategies and timelines.
#CVCT2025: THE FUTURE OF PULMONARY HYPERTENSION TRIALS. Pulmonary arterial hypertension is a severe but treatable disease which has benefited from substantial advances in CT designs and drug development. We'll discuss RCT design in patients treated with approved agents targeting four pathways,
September 10, 2025 at 1:28 PM
#CVCT2025: THE FUTURE OF PULMONARY HYPERTENSION TRIALS. Pulmonary arterial hypertension is a severe but treatable disease which has benefited from substantial advances in CT designs and drug development. We'll discuss RCT design in patients treated with approved agents targeting four pathways,
The Think Tank we have assembled around #cardiacamyloidosis trials will explore prevention, precision, and combination strategies. With leading voices from academia, regulators, industry, and patients, we’ll tackle trial design for early disease, AI-based screening, and endpoints that matter.
September 5, 2025 at 4:10 PM
The Think Tank we have assembled around #cardiacamyloidosis trials will explore prevention, precision, and combination strategies. With leading voices from academia, regulators, industry, and patients, we’ll tackle trial design for early disease, AI-based screening, and endpoints that matter.
#CVCT2025: What constitutes a clinically viable gene therapy candidate for cardiac disease? This section examines recent progress in vector engineering, the identification of disease-specific targets, and advances in molecular tools.
September 2, 2025 at 1:26 PM
#CVCT2025: What constitutes a clinically viable gene therapy candidate for cardiac disease? This section examines recent progress in vector engineering, the identification of disease-specific targets, and advances in molecular tools.
NEW at #CVCT2025: Present your Late-Breaking Clinical Trial at CVCT, a unique platform to share your work with a group of experts with broad experience, including those from academia, clinicians, industry, regulatory bodies, payers, patients & journal editors: www.globalcvctforum.com/late-breakin...
August 25, 2025 at 8:25 AM
NEW at #CVCT2025: Present your Late-Breaking Clinical Trial at CVCT, a unique platform to share your work with a group of experts with broad experience, including those from academia, clinicians, industry, regulatory bodies, payers, patients & journal editors: www.globalcvctforum.com/late-breakin...
#CVCT2025: Structural and valvular interventions have become one of the most exciting areas of innovation in interventional cardiology. At CVCT, we will explore several areas of controversy in the structural heart space including the increasing role of placebo-controlled trials,
August 20, 2025 at 9:56 AM
#CVCT2025: Structural and valvular interventions have become one of the most exciting areas of innovation in interventional cardiology. At CVCT, we will explore several areas of controversy in the structural heart space including the increasing role of placebo-controlled trials,
#CVCT2025: The 2025 Atherosclerosis sessions will emphasize clinical trial design and implementation strategies for multiple classes of lipoprotein altering therapies in patients with established atherosclerotic vascular disease and well as those with ultrarare, rare and more common genetic traits.
August 16, 2025 at 8:20 AM
#CVCT2025: The 2025 Atherosclerosis sessions will emphasize clinical trial design and implementation strategies for multiple classes of lipoprotein altering therapies in patients with established atherosclerotic vascular disease and well as those with ultrarare, rare and more common genetic traits.
Take the ultimate deep dive in major recent clinical trials with the largest global gathering of clinical trials key stakeholders at #CVCT2025, December 8-10, 2025 in Washington DC ! Discover the scientific program here: www.globalcvctforum.com/scientific-p...
#clinicaltrials #clinicalresearch #CVCT
#clinicaltrials #clinicalresearch #CVCT
July 31, 2025 at 10:43 AM
Take the ultimate deep dive in major recent clinical trials with the largest global gathering of clinical trials key stakeholders at #CVCT2025, December 8-10, 2025 in Washington DC ! Discover the scientific program here: www.globalcvctforum.com/scientific-p...
#clinicaltrials #clinicalresearch #CVCT
#clinicaltrials #clinicalresearch #CVCT
[APPLICATIONS FOR 2026] Join the steering committee of an ongoing major clinical trial as a full member with #CVCT Future Trialists Fellowship !
Find out more here: www.globalcvctforum.com/fellowships
Apply here: www.globalcvctforum.com/future-trial...
#clinicalresearch #futuretrialists #fellowship
Find out more here: www.globalcvctforum.com/fellowships
Apply here: www.globalcvctforum.com/future-trial...
#clinicalresearch #futuretrialists #fellowship
July 17, 2025 at 12:28 PM
[APPLICATIONS FOR 2026] Join the steering committee of an ongoing major clinical trial as a full member with #CVCT Future Trialists Fellowship !
Find out more here: www.globalcvctforum.com/fellowships
Apply here: www.globalcvctforum.com/future-trial...
#clinicalresearch #futuretrialists #fellowship
Find out more here: www.globalcvctforum.com/fellowships
Apply here: www.globalcvctforum.com/future-trial...
#clinicalresearch #futuretrialists #fellowship
#CVCT2025: CardioVascular, CardioRenal and Cardiometabolic medicine is the most evidence-based medicine. Every year brings a series of landmark, game changing trials.
www.globalcvctforum.com
#clinicaltrials #clinicalresearch
www.globalcvctforum.com
#clinicaltrials #clinicalresearch
July 15, 2025 at 6:38 PM
#CVCT2025: CardioVascular, CardioRenal and Cardiometabolic medicine is the most evidence-based medicine. Every year brings a series of landmark, game changing trials.
www.globalcvctforum.com
#clinicaltrials #clinicalresearch
www.globalcvctforum.com
#clinicaltrials #clinicalresearch
NEW at #CVCT2025: Present your Late-Breaking Clinical Trial at CVCT, a unique platform to share your work with a group of experts with broad experience, including those from academia, clinicians, industry, regulatory bodies, payers, patients & journal editors: www.globalcvctforum.com/late-breakin...
July 10, 2025 at 2:54 PM
NEW at #CVCT2025: Present your Late-Breaking Clinical Trial at CVCT, a unique platform to share your work with a group of experts with broad experience, including those from academia, clinicians, industry, regulatory bodies, payers, patients & journal editors: www.globalcvctforum.com/late-breakin...
July 4, 2025 at 7:57 AM
CVCT Forum is proud to partner with @jaccjournals.bsky.social to advance our shared mission of promoting rigorous evidence generation and accelerating the global impact of cardiovascular clinical trials.
July 3, 2025 at 12:42 PM
CVCT Forum is proud to partner with @jaccjournals.bsky.social to advance our shared mission of promoting rigorous evidence generation and accelerating the global impact of cardiovascular clinical trials.
#CVCT2025 : REGISTRATION NOW OPEN !
Take the ultimate deep dive in major recent clinical trials with the largest global gathering of clinical trials key stakeholders at #CVCT, December 8-10, 2025 in Washington DC ! Find out more here : www.globalcvctforum.com
#clinicaltrials #clinicalresearch
Take the ultimate deep dive in major recent clinical trials with the largest global gathering of clinical trials key stakeholders at #CVCT, December 8-10, 2025 in Washington DC ! Find out more here : www.globalcvctforum.com
#clinicaltrials #clinicalresearch
June 26, 2025 at 6:30 PM
#CVCT2025 : REGISTRATION NOW OPEN !
Take the ultimate deep dive in major recent clinical trials with the largest global gathering of clinical trials key stakeholders at #CVCT, December 8-10, 2025 in Washington DC ! Find out more here : www.globalcvctforum.com
#clinicaltrials #clinicalresearch
Take the ultimate deep dive in major recent clinical trials with the largest global gathering of clinical trials key stakeholders at #CVCT, December 8-10, 2025 in Washington DC ! Find out more here : www.globalcvctforum.com
#clinicaltrials #clinicalresearch
We are privileged to announce that Dr. Javed Butler will join us as the co-director for the meeting. An accomplished trialist, clinical scientist, and mentor to many, he has been involved with CVCT for a long time and we are excited to have him now be engaged even more at an organizational level.
March 31, 2025 at 7:49 PM
We are privileged to announce that Dr. Javed Butler will join us as the co-director for the meeting. An accomplished trialist, clinical scientist, and mentor to many, he has been involved with CVCT for a long time and we are excited to have him now be engaged even more at an organizational level.